- Home
- AIRT vs LTRN Comparison
AIRT vs LTRN Comparison
Compare AIRT & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRT
- LTRN
- Stock Information
- Founded
- AIRT 1980
- LTRN 2013
- Country
- AIRT United States
- LTRN United States
- Employees
- AIRT N/A
- LTRN N/A
- Industry
- AIRT Air Freight/Delivery Services
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- AIRT Consumer Discretionary
- LTRN Health Care
- Exchange
- AIRT Nasdaq
- LTRN Nasdaq
- Market Cap
- AIRT 61.2M
- LTRN 49.9M
- IPO Year
- AIRT N/A
- LTRN 2020
- Fundamental
- Price
- AIRT $18.35
- LTRN $3.05
- Analyst Decision
- AIRT
- LTRN Strong Buy
- Analyst Count
- AIRT 0
- LTRN 1
- Target Price
- AIRT N/A
- LTRN $25.00
- AVG Volume (30 Days)
- AIRT 1.4K
- LTRN 99.3K
- Earning Date
- AIRT 11-12-2025
- LTRN 11-12-2025
- Dividend Yield
- AIRT N/A
- LTRN N/A
- EPS Growth
- AIRT N/A
- LTRN N/A
- EPS
- AIRT N/A
- LTRN N/A
- Revenue
- AIRT $279,216,000.00
- LTRN N/A
- Revenue This Year
- AIRT N/A
- LTRN N/A
- Revenue Next Year
- AIRT N/A
- LTRN N/A
- P/E Ratio
- AIRT N/A
- LTRN N/A
- Revenue Growth
- AIRT N/A
- LTRN N/A
- 52 Week Low
- AIRT $14.56
- LTRN $2.55
- 52 Week High
- AIRT $26.70
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- AIRT 26.31
- LTRN 29.07
- Support Level
- AIRT $20.93
- LTRN $3.16
- Resistance Level
- AIRT $21.00
- LTRN $3.55
- Average True Range (ATR)
- AIRT 0.34
- LTRN 0.26
- MACD
- AIRT -0.36
- LTRN -0.03
- Stochastic Oscillator
- AIRT 0.00
- LTRN 3.06
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.